<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01021631</url>
  </required_header>
  <id_info>
    <org_study_id>Transfusion</org_study_id>
    <nct_id>NCT01021631</nct_id>
  </id_info>
  <brief_title>TRACS STUDY: Transfusion Requirements After Cardiac Surgery</brief_title>
  <acronym>TRACS</acronym>
  <official_title>Transfusion Requirements After Cardiac Surgery: a Randomized Controlled Clinical Trial (TRACS STUDY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto do Coracao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto do Coracao</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Blood transfusion is related to worse outcomes and the triggers for red blood cells
      transfusion are not well defined in cardiac surgery. Retrospective studies in cardiac surgery
      do not show benefits of red blood cell transfusion in reduction of morbidity and mortality in
      cardiac surgery. There are no prospective studies comparing outcomes between restrictive or
      liberal strategy in cardiac surgery.This study is a double-blind randomized study comparing
      clinical outcomes between two strategies of transfusion in cardiac surgery - liberal or
      restrictive.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood transfusion is commonly performed in patients submitted to cardiac surgery. However,
      there are many studies reporting adverse effects of this intervention and final data on
      benefits are not available. There are no prospective studies in cardiac surgery regarding red
      blood cell transfusions requirements. There are retrospective studies in cardiac surgery
      suggesting worse outcomes including higher rates of mortality in patients submitted to red
      blood transfusion. Hematocrit levels around 30% are usually recommended not evidence based.
      Our purpose is to prospectively evaluate two strategies of transfusion in 500 patients
      submitted to elective cardiac surgery: a liberal strategy - patients receive blood
      transfusion when hematocrit is lower than 30% since the intraoperative period until the ICU
      discharge; a restrictive strategy - patients receive blood transfusion only when hematocrit
      is lower than 24%.

      Clinical outcomes, costs and quality of life will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2009</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">February 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary purpose of this study is to compare clinical outcomes after cardiac surgery in patients submitted to different strategies of red blood cell transfusion</measure>
    <time_frame>30 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare length of stay in ICU, length of stay in Hospital, health-related quality of life, hospital costs and mortality between groups.</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Liberal Transfusion Strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liberal Group - transfusion when hematocrit is lower than 30%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restrictive Transfusion Strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Restrictive Group - transfusion when hematocrit is lower than 24%</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Red blood cell transfusion</intervention_name>
    <description>Red blood cell (RBC) transfusion will be given when hematocrit fall below 30% since intraoperative until the discharge of intensive care unit. Following administration of the 1 RBC unit, a repeat hematocrit is performed;if a patient's hematocrit is 30% or higher, no additional transfusion is necessary.</description>
    <arm_group_label>Liberal Transfusion Strategy</arm_group_label>
    <other_name>Red blood cells</other_name>
    <other_name>Transfusion</other_name>
    <other_name>Liberal</other_name>
    <other_name>Cardiac surgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Red blood cell transfusion</intervention_name>
    <description>Red blood cell (RBC) transfusion will be only given when hematocrit fall below 24% since intraoperative until the discharge of intensive care unit. Following administration of the 1 RBC unit, a repeat hematocrit is performed;if a patient's hematocrit is 24% or higher, no additional transfusion is necessary.</description>
    <arm_group_label>Restrictive Transfusion Strategy</arm_group_label>
    <other_name>Red blood cells</other_name>
    <other_name>Transfusion</other_name>
    <other_name>Restrictive</other_name>
    <other_name>Cardiac surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All elective primary and redo adult cardiac surgical patients for coronary artery
             bypass grafting, valve procedure or combined procedures

          -  Adults patients

          -  Written informed consent

        Exclusion Criteria:

          -  Age less than 18 years

          -  Transplant procedures

          -  Emergency procedures

          -  Aortic repairs

          -  Congenital procedures

          -  Previous anemia (hemoglobin lower than 10 g/dL)

          -  Previous thrombocytopenia (platelet number lower than 100.000/mm3)

          -  Previous known coagulopathy

          -  Pregnancy

          -  Those unable to receive blood transfusion

          -  Patients who refused participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ludhmila A Hajjar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>InCor - HCFMUSP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ludhmila A Hajjar, MD</last_name>
    <phone>55-11-93194401</phone>
    <email>ludhmila@terra.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Filomena R Galas, MD, PhD</last_name>
    <phone>55-11-93190441</phone>
    <email>filomenagalas@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>InCor - Faculdade de Medicina da Universidade de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludhmila A Hajjar, MD</last_name>
      <phone>55-11-93194401</phone>
      <email>ludhmila@terra.com.br</email>
    </contact>
    <contact_backup>
      <last_name>Filomena R Galas, MD, PhD</last_name>
      <phone>55-11-93190441</phone>
      <email>filomenagalas@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ludhmila A Hajjar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Filomena R Galas, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosana E Nakamura, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carolina Silva, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paulo C Bueno, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Kalil Filho, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Louis Vincent, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Otavio C Auler Jr, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thais Mauad, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Hajjar LA, Auler Junior JO, Santos L, Galas F. Blood tranfusion in critically ill patients: state of the art. Clinics (Sao Paulo). 2007 Aug;62(4):507-24. Review.</citation>
    <PMID>17823715</PMID>
  </reference>
  <reference>
    <citation>Auler JO Jr, Galas F, Hajjar L, Santos L, Carvalho T, Michard F. Online monitoring of pulse pressure variation to guide fluid therapy after cardiac surgery. Anesth Analg. 2008 Apr;106(4):1201-6, table of contents. doi: 10.1213/01.ane.0000287664.03547.c6.</citation>
    <PMID>18349193</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2009</study_first_submitted>
  <study_first_submitted_qc>November 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2009</study_first_posted>
  <last_update_submitted>November 27, 2009</last_update_submitted>
  <last_update_submitted_qc>November 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jose Otavio Costa Auler Jr</name_title>
    <organization>InCor - HCFMUSP</organization>
  </responsible_party>
  <keyword>Cardiac surgery</keyword>
  <keyword>Strategies of transfusion</keyword>
  <keyword>Red blood cells</keyword>
  <keyword>Liberal</keyword>
  <keyword>Restrictive</keyword>
  <keyword>Anemia</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

